Recursion Pharmaceuticals Inc (RXRX) Event June 21, 2022, 12:04 UTC 12 1 comments (80% Positive) RECURSION PHARMACEUTICALS, INC. (RXRX) Announces Enrollment Update for designations Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment Comment Full text
Prelude Therapeutics (PRLD) Event June 21, 2022, 12:00 UTC 12 1 comments (99% Neutral) Prelude Therapeutics Inc (PRLD) Files Form 8-K Comment Full text
Tonix Pharmaceuticals Holding Corp (TNXP) Event June 21, 2022, 11:06 UTC 11 1 comments (99% Neutral) TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) Announces Clinical Development Update Comment Full text
Karuna Therapeutics (was acquised by Bristol Myers Squibb (NYSE: BMY) on 18/03/2024) (KRTX) Event June 21, 2022, 11:06 UTC 12 1 comments (99% Neutral) KARUNA THERAPEUTICS, INC. (KRTX) Announces Regulatory Update Comment Full text
Xenon Pharmaceuticals Inc (XENE) Event June 21, 2022, 11:03 UTC 12 1 comments (10% Negative) XENON PHARMACEUTICALS INC. (XENE) Announces Delay in patients Development Timeline Due to Geopolitical Situation, Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment Comment Full text
Guardant Health Inc (GH) Event June 21, 2022, 11:01 UTC 13 1 comments (99% Neutral) GUARDANT HEALTH, INC. (GH) Announces Regulatory Update Comment Full text
AstraZeneca (AZN) Event June 21, 2022, 10:24 UTC 9 1 comments (80% Positive) AstraZeneca (AZN) Announces Clinical Development Update (Form 6-K) Comment Full text
ORIC Pharmaceuticals Inc (ORIC) Event June 21, 2022, 10:08 UTC 10 1 comments (99% Neutral) ORIC Pharmaceuticals, Inc. (ORIC) Files Form 8-K Comment Full text
Ionis Pharmaceuticals Inc (IONS) Event June 21, 2022, 10:03 UTC 12 1 comments (90% Positive) IONIS PHARMACEUTICALS, INC. (IONS) Provides Update on treatments for a range of unmet medical needs Comment Full text
Brooklyn ImmunoTherapeutics Inc (the company was transformed Eterna Therapeutics (ERNA)) (BTX) Event June 17, 2022, 21:21 UTC 12 1 comments (99% Neutral) Brooklyn ImmunoTherapeutics, Inc. (BTX) Announces Clinical Development Update Comment Full text